Insider Selling: Mead Johnson Nutrition Director Sells 10,000 Shares of Stock (MJN)
Mead Johnson Nutrition (NYSE:MJN) Director Stephen W. Golsby sold 10,000 shares of the stock on the open market in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $83.12, for a total transaction of $831,200.00. Following the transaction, the director now directly owns 90,920 shares in the company, valued at approximately $7,557,270. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Mead Johnson Nutrition (NYSE:MJN) traded down 0.55% during mid-day trading on Wednesday, hitting $83.49. 1,174,940 shares of the company’s stock traded hands. Mead Johnson Nutrition has a one year low of $65.38 and a one year high of $86.87. The stock has a 50-day moving average of $83.96 and a 200-day moving average of $78.55. The company has a market cap of $16.864 billion and a P/E ratio of 27.09.
Mead Johnson Nutrition (NYSE:MJN) last announced its earnings results on Thursday, October 24th. The company reported $0.91 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.79 by $0.12. The company had revenue of $1.05 billion for the quarter, compared to the consensus estimate of $998.04 million. During the same quarter last year, the company posted $0.71 earnings per share. Mead Johnson Nutrition’s revenue was up 13.6% compared to the same quarter last year. On average, analysts predict that Mead Johnson Nutrition will post $3.37 earnings per share for the current fiscal year.
A number of analysts have recently weighed in on MJN shares. Analysts at Zacks upgraded shares of Mead Johnson Nutrition from a “neutral” rating to an “outperform” rating in a research note to investors on Tuesday. They now have a $86.80 price target on the stock. Separately, analysts at Deutsche Bank raised their price target on shares of Mead Johnson Nutrition from $86.00 to $94.00 in a research note to investors on Monday, December 9th. They now have a “buy” rating on the stock. Finally, analysts at Deutsche Bank reiterated a “positive” rating on shares of Mead Johnson Nutrition in a research note to investors on Monday, December 9th. Nine investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $86.48.
Mead Johnson Nutrition Company (NYSE:MJN) is a global pediatric nutrition company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.